Epigenetic therapy in lung cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Epigenetic deregulation is a key factor in cancer development, particularly lung cancer.
• Epigenetic alterations, such as DNA methylation and histone modifications, contribute to lung carcinogenesis.
• The reversible nature of epigenetic changes presents unique therapeutic opportunities.

Purpose of the Study:

• To review the therapeutic implications of epigenetic alterations in lung cancer.
• To discuss recent advances in epigenetic-based therapeutic strategies for lung cancer.
• To highlight the potential of targeting DNA methylation and histone acetylation.

Main Methods:

• Literature review of epigenetic mechanisms in lung cancer.
• Analysis of current therapeutic strategies targeting epigenetic modifications.
• Synthesis of recent research on DNA methylation and histone acetylation inhibitors.

Main Results:

• Epigenetic modifications are crucial in the pathogenesis of lung cancer.
• Therapeutic targeting of DNA methylation and histone acetylation shows promise.
• Reversibility of epigenetic changes offers a window for intervention.

Conclusions:

• Epigenetic deregulation is a significant driver of lung cancer.
• Targeting epigenetic mechanisms, specifically DNA methylation and histone acetylation, represents a viable therapeutic approach.
• Further research into epigenetic therapies could lead to improved lung cancer treatment outcomes.